Saccharomyces Boulardii

by Kirkman · capsule · 100 capsules

  • On the market (NIH)
  • UPC 8 12325 02076 8
  • DSLD label 297249
  • Serving 1 capsule
  • 100 servings

Saccharomyces Boulardii by Kirkman lists one ingredient: 150 mg of saccharomyces boulardii per serving of 1 capsule. Its current label entered the NIH Dietary Supplement Label Database on October 24, 2023.

What is in Saccharomyces Boulardii?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Saccharomyces Boulardii: Supplement Facts rows against the market (DSLD label 297249, January 2026 release)
IngredientAmount% DVAmong products listing it
Saccharomyces boulardii3 Billion CFU (at time of manufacture)150 mgSaccharomyces boulardii in Saccharomyces Boulardii against 78 products150 mg per serving; the middle half of products list 250 mg to 500 mg, the median 250 mg.150 mg

82% of 78 products listing saccharomyces boulardii give more (median 250 mg).

Source: NIH ODS Dietary Supplement Label Database, label 297249 (entered October 24, 2023), version 9.4.0. See the label on DSLD or its label image (PDF). Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested use: Take one capsule daily on an empty stomach or as directed by a physician.
Warnings
Keep out of the reach of children.
Caution: Formulated for adults and children four years and older. For children under four, consult a physician.
Allergens and what it does not contain
Free of: Milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soy, and sesame
Gluten-free
Storage
Important: Refrigerate after opening. Keep bottle tightly capped.

Source: label statements in DSLD label 297249.

What else is on the label?

Other ingredients: Hypromellose, Water.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): Ultra Tested cGMP.

How many labels does Saccharomyces Boulardii have?

2 labels are on file under this name since September 25, 2013: other sizes, label designs and reformulations. The current one leads this page.

  1. Label 297249 (current) Entered October 24, 2023 · on the market · 100 capsules · UPC 8 12325 02076 8
  2. Label 25276 Entered September 25, 2013 · on the market · 60 capsules

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Kirkman (manufacturer), Lake Oswego, OR. All Kirkman products.

Where next?